会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明公开
    • 양친성 저분자량 히알루론산 복합체를 포함하는 나노 입자 및 그의 제조 방법
    • 包含高分子量低分子量羟基丙酸复合物的纳米颗粒及其制备方法
    • KR1020130117361A
    • 2013-10-25
    • KR1020130123611
    • 2013-10-16
    • 씨제이헬스케어 주식회사
    • 김유미윤명식이하영임동권임선경기소영김세환박지은박지혜이정록이주현조일환홍은미홍혜숙
    • A61K47/48A61K47/36A61K47/30A61K9/16
    • A61K9/1617A61K9/1652A61K47/28A61K47/36B82Y5/00
    • PURPOSE: A nanoparticle containing a low molecular weight amphiphilic hyaluronic acid composite is provided to show superior water solubility compared with an existing drug delivery system and to encapsulate high volume drugs with high efficiency. CONSTITUTION: A low molecular weight hyaluronic acid-5-beta cholanic acid composite is an amphiphilic composite in which 5-beta-cholanic acid is conjugated to hyaluronic acid with a molecular weight of 5-20 kDa. The composite forms self-aggregates in water. Nanoparticles are formed by encapsulating a hydrophobic drug in the composite. A method for preparing the nanoparticles comprises the steps of: synthesizing 5-beta cholanic acid with a cholanic acid structure using aminoethyl cholanoamide; dissolving the hyaluronic acid with a molecular weight of 5-20 kDa in an aqueous solvent to prepare a hyaluronic acid solution; dissolving aminoethyl cholanoamide in an organic solvent to prepare a cholanoamide solution; adding the cholanoamide solution to the hyaluronic acid solution and preparing a reactant solution; depositing the hyaluronic acid-5-beta cholanic acid composite from the reactant solution; and encapsulating a drug in the hyaluronic acid-5-beta cholanic acid.
    • 目的:提供含有低分子量两亲透明质酸复合材料的纳米粒子,与现有的药物输送系统相比显示出优异的水溶性,并且以高效率包封大量药物。 构成:低分子量透明质酸-5-β胆酸复合物是两亲性复合物,其中5-β-胆酸与分子量为5-20kDa的透明质酸缀合。 复合物在水中形成自聚集体。 通过将疏水性药物包封在复合材料中形成纳米颗粒。 制备纳米颗粒的方法包括以下步骤:使用氨基乙基胆酰胺合成具有胆酸结构的5-β胆酸; 将分子量为5-20kDa的透明质酸溶解在水性溶剂中以制备透明质酸溶液; 将氨基乙基胆酰胺溶解在有机溶剂中以制备胆酰胺溶液; 将胆酰胺溶液加入到透明质酸溶液中并制备反应物溶液; 从反应物溶液沉积透明质酸-5-β胆酸复合物; 并将药物包封在透明质酸-5-β胆酸中。